Published in Antimicrob Agents Chemother on June 01, 1976
Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases. Antimicrob Agents Chemother (1979) 4.93
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 3.88
In vitro evaluation of Ro 13-9904. Antimicrob Agents Chemother (1980) 2.67
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin. Antimicrob Agents Chemother (1980) 2.20
Common mechanism of ampC beta-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene. J Bacteriol (1987) 2.13
Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrob Agents Chemother (1981) 2.11
In vitro response of Enterobacter to ampicillin. Antimicrob Agents Chemother (1979) 2.06
Cefuroxime, an in vitro Comparison with Six Other Cephalosporins. Proc R Soc Med (1977) 2.06
Dissociated resistance among cephalosporins. Antimicrob Agents Chemother (1979) 2.01
SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother (1978) 1.81
Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae. Antimicrob Agents Chemother (1979) 1.74
Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 1.71
In vitro activity of U-76,252 (CS-807), a new oral cephalosporin. Antimicrob Agents Chemother (1988) 1.65
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae. Antimicrob Agents Chemother (1987) 1.55
Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia. J Clin Microbiol (1980) 1.44
Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae. Antimicrob Agents Chemother (1987) 1.39
Development of resistance to cephalosporins in clinical strains of Citrobacter spp. Antimicrob Agents Chemother (1984) 1.38
Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide. Antimicrob Agents Chemother (1979) 1.30
Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamase. J Clin Microbiol (1992) 1.14
Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime. Antimicrob Agents Chemother (1979) 1.12
Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits. J Clin Microbiol (1982) 1.10
Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests. Antimicrob Agents Chemother (1982) 1.02
Therapy of lower respiratory tract infections with moxalactam. Antimicrob Agents Chemother (1981) 0.99
Bacterial antibiotic resistance before and after clinical application in the United States. Bull N Y Acad Med (1987) 0.90
Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro. Antimicrob Agents Chemother (1977) 0.90
Transfer of the chromosomal bla gene from Enterobacter cloacae to Escherichia coli by RP4::mini-Mu. J Bacteriol (1984) 0.87
Microbiological investigation of cephalosporins. Drugs (1987) 0.83
Antibacterial activity of cefoperazone alone and in combination against cephalosporinase-producing Enterobacter cloacae. Antimicrob Agents Chemother (1983) 0.83
What do beta-lactamases mean for clinical efficacy? Infection (1983) 0.79
The changing ecology of hospital bacteria and the selective role of cephalosporins. Epidemiol Infect (1991) 0.78
Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system. J Clin Microbiol (1980) 0.75
Cefotaxime therapy of serious bacterial infection in adults. Antimicrob Agents Chemother (1982) 0.75
Cefotiam susceptibility testing criteria. J Clin Microbiol (1985) 0.75
Replica plating and indirect selection of bacterial mutants. J Bacteriol (1952) 59.66
Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 40.37
Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother (1974) 10.72
Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother (1973) 8.83
Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med (1971) 8.13
Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics. Antimicrob Agents Chemother (1972) 7.71
Observations on the nature, distribution, and significance of cephalosporinase. Lancet (1963) 6.56
Inducible beta-lactamase in Enterobacter. J Gen Microbiol (1967) 3.75
Spontaneous mutant with loss of beta-lactamase in Aerobacter cloacae. J Bacteriol (1969) 3.57
Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins. Antimicrob Agents Chemother (1972) 3.50
Characteristics of Aerobacter beta-lactamase. Can J Microbiol (1968) 3.28
Relationship Between beta-Lactamase Activity and Resistance of Enterobacter to Cephalothin. Infect Immun (1970) 2.67
NATURAL AND ACQUIRED RESISTANCE OF KLEBSIELLA-AEROBACTER TO CEPHALOTHIN AND CEPHALORIDINE. Proc Soc Exp Biol Med (1965) 2.47
Use of cellulose acetate membranes for detecting penicillinase-producing organisms. Nature (1961) 2.15
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 40.37
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
Comparative study of the efficacy of seven paper-reagent strips and conventional biochemical tests in identifying gram-negative organisms. Appl Microbiol (1969) 8.23
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99
Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother (1983) 5.10
Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol (1972) 3.55
Methods and significance of in vitro testing of bacterial sensitivity to drugs. Am J Med (1965) 3.50
Subgingival microflora and periodontitis. J Periodontal Res (1976) 2.30
Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin. Ann N Y Acad Sci (1967) 2.12
In vitro response of Enterobacter to ampicillin. Antimicrob Agents Chemother (1979) 2.06
Stability of antibiotics and chemotherapeutics in agar plates. Appl Microbiol (1970) 1.75
Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. Antimicrob Agents Chemother (1977) 1.72
The clinical significance of Aeromonas hydrophila. Report of two cases. Arch Intern Med (1966) 1.72
Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 1.71
Relationship of early readings of minimal inhibitory concentrations to the results of overnight tests. Antimicrob Agents Chemother (1975) 1.65
Decreased incidence of antibiotic resistance among Staphylococcus aureus. A study in a university hospital over a 9-year period. Ann Intern Med (1968) 1.60
Influence of different media and bloods on results of diffusion antibiotic susceptibility tests. Antimicrob Agents Chemother (1972) 1.59
Development of resistance to cephalosporins in clinical strains of Citrobacter spp. Antimicrob Agents Chemother (1984) 1.38
Susceptibility of Neisseria gonorrhoeae to penicillin and tetracycline. Antimicrob Agents Chemother (Bethesda) (1968) 1.36
Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother (1986) 1.32
Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology. Ann N Y Acad Sci (1974) 1.08
Changing incidence of antibiotic resistance among Staphylococcus aureus, Escherichia coli, Aerobacter-Klebsiella, and Pseudomonas encountered in a teaching hospital over a 7-year period. Antimicrob Agents Chemother (Bethesda) (1966) 1.05
Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol (1966) 1.03
Anal carriage as the probable source of a streptococcal epidemic. Lancet (1966) 1.03
The susceptibility of Clostridium perfringens type A to ampicillin and penicillin G in vitro. Chemotherapy (1968) 1.02
Antibiotic susceptibilities of Neisseria Gonorrheae isolates. Northwest Med (1967) 1.01
Studies on the interaction between serum bactericidal activity and antibiotics in vitro. Chemotherapy (1970) 0.96
Decreased incidences of resistance to antimicrobial agents among Escherichia coli and Klebsiella-enterobacter. Observations in a university hospital over a 10-year period. Ann Intern Med (1970) 0.94
Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests. Antimicrob Agents Chemother (1979) 0.91
Antimicrobial susceptibility testing. Hum Pathol (1976) 0.91
Electrical impedance measurements in the reading and monitoring of broth dilution susceptibility tests. Antimicrob Agents Chemother (1977) 0.88
Disseminated osteomyelitis due to "Battey" mycobacteria. Am Rev Respir Dis (1966) 0.87
The demonstration of specific urinary anti-bodies in urinary tract infections caused by Gram-negative bacilli. J Pathol Bacteriol (1966) 0.86
In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study. Am J Clin Pathol (1979) 0.81
Graduate training in dermatology. Changing undergraduate curricula and their relationship to postgraduate education. Arch Dermatol (1969) 0.79
Anal streptococci. N Engl J Med (1969) 0.79
Fluorescent antibody staining of group A streptococci: demonstration and elimination of blocking antibody. J Infect Dis (1967) 0.78
Reproducibility of control strains for antibiotic susceptibility testing. Antimicrob Agents Chemother (1976) 0.76